What are oligometastases?

Joachim Pfannschmidt (Berlin, Germany)

Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Session: Oligometastasis: postmodern multimodality concepts
Session type: Symposium
Number: 3473

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Joachim Pfannschmidt (Berlin, Germany). What are oligometastases?. International Congress 2016 – Oligometastasis: postmodern multimodality concepts

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too!
Source: Eur Respir J 2016; 48: 276-278
Year: 2016


Prehabilitation can turn inoperable patients with NSLC to operable ones?
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020


Genetics and evolution of primaries and oligometastases
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016


Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019


What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011


Palliative care or standard chemotherapy in lung cancer patients?
Source: Annual Congress 2012 - Ethics Grand Round: an interactive session
Year: 2012


Detection of operable lung cancer – a question of sheer luck?
Source: Eur Respir J 2007; 30: Suppl. 51, 563s
Year: 2007

Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Source: Eur Respir J 2012; 39: 1039-1042
Year: 2012


Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011

Is there a role for radiotherapy in mediastinal tumours?
Source: Annual Congress 2013 –Mediastinal tumours excluding thymoma
Year: 2013


Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Follow-up after lung cancer resection: is intensified also justified?
Source: Eur Respir J 2013; 42: 1178-1179
Year: 2013


Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006